Pharma Tech

Moderna hitches a ride with Uber to boost vaccine confidence—and, of course, drive access

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two companies say they're planning to work together to promote vaccine confidence and ease access to coronavirus shots.

Early ideas include promoting vaccine safety on the Uber network and through in-app messages as well as incorporating Uber rides into the vaccination scheduling process.

While those details are still in the works, the appeal of Uber as a partner for Moderna is not only its nationwide network and connections but also the diversity of its 1.2 million drivers.

“Uber has broad access across the United States—its ride-sharing platform is used by Americans everywhere, and its drivers represent a wide variety of the population," Michael Mullette, Moderna's vice president of commercial operations in North America, said. "There’s a great opportunity for us to think about educating the population about how do you get immunized … but also how do you access credible information about vaccines."

The deal comes amid a U.S. vaccine rollout hobbled by confusion, lack of centralized government planning and distribution headaches. Even when vaccines are readily available and easy to access, fear is hampering uptake, thanks to the unprecedented speed of vaccine development, historical abuse of the Black community in biomedical research and more generalized anti-vaxxer sentiment.

Last month, Uber pledged 10 million free or discounted rides for underserved populations who may have difficulty with transportation to get vaccines. The company is partnering with the National Urban League, the Morehouse School of Medicine and the National Action Network to focus on communities of color where people have been disproportionately affected by COVID-19.

Spotlight

Spotlight

Related News